Hologic appoints new CEO
This article was originally published in Clinica
Executive Summary
Robert Cascella has been named as CEO of Hologic. He will succeed Jack Cumming, who remains chairman and a member of the executive management team. Mr Cascella joined the company in February 2003 as chief operating officer, and was promoted to president in September 2003. Before this he had been a managing partner of CFG Capital, an investment banking firm specialising in healthcare, since 1998. Bedford, Massachusetts-based Hologic markets in vitro diagnostics for cervical cancer screening, preterm birth and prenatal genetic analysis, as well as imaging systems for breast cancer and osteoporosis, and other women's health products.